Atlas Trials

Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency

Clinical trial NCT02213653 · TERMINATED

Trial details

NCT number
NCT02213653
Sponsor
Centre Francois Baclesse
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Solid Cancer Metastatic DiseaseLymphoid Disease
Start date
2013-04-01
Primary completion
2014-11-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.